Cargando…
COVID‐19 and dexamethasone‐induced hyperglycaemia: Workload implications for diabetes inpatient teams
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646374/ https://www.ncbi.nlm.nih.gov/pubmed/34651335 http://dx.doi.org/10.1111/dme.14716 |
| _version_ | 1784610492116893696 |
|---|---|
| author | Younes, Younes R. Stockley, Susan Keegan, Lorna O’Donoghue, Linda Yohannan, Elizabeth Read, Liz Williamson, Jamie‐Leigh Peter, John Lakshmipathy, Kavitha Smout, Vera Nayyar, Vidhu Emmanuel, Julian Zachariah, Sunil Clark, James Field, Benjamin C. T. |
| author_facet | Younes, Younes R. Stockley, Susan Keegan, Lorna O’Donoghue, Linda Yohannan, Elizabeth Read, Liz Williamson, Jamie‐Leigh Peter, John Lakshmipathy, Kavitha Smout, Vera Nayyar, Vidhu Emmanuel, Julian Zachariah, Sunil Clark, James Field, Benjamin C. T. |
| author_sort | Younes, Younes R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8646374 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86463742021-12-06 COVID‐19 and dexamethasone‐induced hyperglycaemia: Workload implications for diabetes inpatient teams Younes, Younes R. Stockley, Susan Keegan, Lorna O’Donoghue, Linda Yohannan, Elizabeth Read, Liz Williamson, Jamie‐Leigh Peter, John Lakshmipathy, Kavitha Smout, Vera Nayyar, Vidhu Emmanuel, Julian Zachariah, Sunil Clark, James Field, Benjamin C. T. Diabet Med Letters John Wiley and Sons Inc. 2021-10-22 2022-02 /pmc/articles/PMC8646374/ /pubmed/34651335 http://dx.doi.org/10.1111/dme.14716 Text en © 2021 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters Younes, Younes R. Stockley, Susan Keegan, Lorna O’Donoghue, Linda Yohannan, Elizabeth Read, Liz Williamson, Jamie‐Leigh Peter, John Lakshmipathy, Kavitha Smout, Vera Nayyar, Vidhu Emmanuel, Julian Zachariah, Sunil Clark, James Field, Benjamin C. T. COVID‐19 and dexamethasone‐induced hyperglycaemia: Workload implications for diabetes inpatient teams |
| title | COVID‐19 and dexamethasone‐induced hyperglycaemia: Workload implications for diabetes inpatient teams |
| title_full | COVID‐19 and dexamethasone‐induced hyperglycaemia: Workload implications for diabetes inpatient teams |
| title_fullStr | COVID‐19 and dexamethasone‐induced hyperglycaemia: Workload implications for diabetes inpatient teams |
| title_full_unstemmed | COVID‐19 and dexamethasone‐induced hyperglycaemia: Workload implications for diabetes inpatient teams |
| title_short | COVID‐19 and dexamethasone‐induced hyperglycaemia: Workload implications for diabetes inpatient teams |
| title_sort | covid‐19 and dexamethasone‐induced hyperglycaemia: workload implications for diabetes inpatient teams |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646374/ https://www.ncbi.nlm.nih.gov/pubmed/34651335 http://dx.doi.org/10.1111/dme.14716 |
| work_keys_str_mv | AT younesyounesr covid19anddexamethasoneinducedhyperglycaemiaworkloadimplicationsfordiabetesinpatientteams AT stockleysusan covid19anddexamethasoneinducedhyperglycaemiaworkloadimplicationsfordiabetesinpatientteams AT keeganlorna covid19anddexamethasoneinducedhyperglycaemiaworkloadimplicationsfordiabetesinpatientteams AT odonoghuelinda covid19anddexamethasoneinducedhyperglycaemiaworkloadimplicationsfordiabetesinpatientteams AT yohannanelizabeth covid19anddexamethasoneinducedhyperglycaemiaworkloadimplicationsfordiabetesinpatientteams AT readliz covid19anddexamethasoneinducedhyperglycaemiaworkloadimplicationsfordiabetesinpatientteams AT williamsonjamieleigh covid19anddexamethasoneinducedhyperglycaemiaworkloadimplicationsfordiabetesinpatientteams AT peterjohn covid19anddexamethasoneinducedhyperglycaemiaworkloadimplicationsfordiabetesinpatientteams AT lakshmipathykavitha covid19anddexamethasoneinducedhyperglycaemiaworkloadimplicationsfordiabetesinpatientteams AT smoutvera covid19anddexamethasoneinducedhyperglycaemiaworkloadimplicationsfordiabetesinpatientteams AT nayyarvidhu covid19anddexamethasoneinducedhyperglycaemiaworkloadimplicationsfordiabetesinpatientteams AT emmanueljulian covid19anddexamethasoneinducedhyperglycaemiaworkloadimplicationsfordiabetesinpatientteams AT zachariahsunil covid19anddexamethasoneinducedhyperglycaemiaworkloadimplicationsfordiabetesinpatientteams AT clarkjames covid19anddexamethasoneinducedhyperglycaemiaworkloadimplicationsfordiabetesinpatientteams AT fieldbenjaminct covid19anddexamethasoneinducedhyperglycaemiaworkloadimplicationsfordiabetesinpatientteams |